Back to Search
JOHN GOLAY, MD
MD
Family Medicine Physician
NPI: 1215944137IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 1977
Research & Publications (20)
A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma.
PMID 19633847·Ann Hematol·2010
3-trial
M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
PMID 19299742·J Immunol·2009
8-other
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
PMID 19375652·Exp Hematol·2009
8-other
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs.
PMID 19462317·Cytotherapy·2009
8-other
The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2(V617F).
PMID 18079739·Leukemia·2008
8-other
Chemokines and antagonists in non-Hodgkin's lymphoma.
PMID 18410244·Expert Opin Ther Targets·2008
6-review
FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab.
PMID 17650444·Haematologica·2007
4-observational
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
PMID 17637810·Leukemia·2007
7-preclinical
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study.
PMID 17606446·Haematologica·2007
3-trial
The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximab.
PMID 17475893·J Immunol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 811 WEST MAIN STREET, STE 207
LEXINGTON, SC 29072 - Phone
- (803) 358-6420
Quick Facts
- NPI
- 1215944137
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile